Nicotinell Menthe (Nicotine Bitartrate Dihydrate)

Nicotine, the active ingredient in Nicotinell Menthe, is a nicotine replacement therapy presented as an oromucosal product for oral use. It is intended to aid adults who are trying to quit smoking by reducing nicotine cravings and withdrawal symptoms. The formulation is designed for discreet, convenient use throughout the day and is packaged to maintain stability.

GNH USA supplies Nicotinell Menthe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance and regulatory conformity across EU and other markets.

Nicotinell Menthe, a nicotine replacement therapy, is used in smoking cessation to manage nicotine dependence.

- Smoking cessation: helps reduce cravings and withdrawal symptoms, supporting a quit attempt. - Tobacco dependence: provides controlled nicotine delivery to replace cigarettes and facilitate gradual reduction. - Relapse prevention: assists former smokers in maintaining abstinence by mitigating occasional urges.

Nicotinell Menthe may cause a range of oral and systemic reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness after use. - Headache: mild headache that usually resolves without intervention. - Dizziness: brief light‑headedness, especially when first used.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing requiring immediate medical attention. - Persistent hypertension: significant rise in blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heartbeat reported rarely, necessitating evaluation.

When using Nicotinell Menthe, consider the following precautions to ensure safe and effective use. - Contraindication: avoid use in individuals with known hypersensitivity to nicotine or product excipients. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a clinician, as nicotine can be transferred via breast milk. - Cardiovascular disease: use with caution in patients with uncontrolled hypertension, arrhythmias, or recent myocardial infarction. - Medication interactions: inform the prescriber of all concurrent drugs, especially monoamine oxidase inhibitors or other nicotine products. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nicotinell Menthe can interact with certain medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Other nicotine products: concurrent use can lead to nicotine overdose and severe cardiovascular effects. - Monoamine oxidase inhibitors (MAOIs): combined use may increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance nicotine’s effect on mood, requiring monitoring. - Antihypertensive agents: nicotine can counteract blood‑pressure‑lowering effects, necessitating dose adjustments. - Caffeine‑containing medications: nicotine may potentiate stimulant effects, leading to jitteriness.